Device Trial Radar · NCT07086742
Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate
Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
53
Actual
Start
Jul 20, 2025
Primary completion
Nov 23, 2025
Study completion Nov 23, 2025
Sponsor
- Lead sponsor
- Pathway Medtech, LLC.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Haku Technology
- First posted
- Jul 25, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical study is to investigate a new medical device, the Smart Mask V1 System (herein 'Smart Mask'), and particularly its measurements of blood oxygen levels (SpO2) and pulse rate (PR) in healthy adults aged 18 to 65. More specifically, the study is directed at answering the following questions: * Can the Smart Mask accurately measure SpO2 levels compared to established reference devices (reference oximeters, blood gas) throughout the range of SpO2 \~ 70 - 100%? * Can the Smart Mask accurately measure PR during the same conditions? * Does skin pigmentation impact the accuracy of Smart Mask's measurements of SpO2 and PR. The following reference devices will be used in the study: * An FDA-cleared fingertip pulse oximeter (Nellcor Portable SpO2 Patient Monitoring System, PM10N) * A laboratory-grade CO-oximeter (Radiometer ABL90 FLEX) that analyzes oxygen saturation from blood samples. Study participants will: * Wear the Smart Mask on their face and a fingertip pulse oximeter while lying down * Breathe air with gradually reduced oxygen levels inside a specialized hypoxia room while being closely. * In a second phase of the study, have a catheter inserted into a wrist artery for blood sampling to directly measure oxygen levels with the CO-oximeter.
Conditions
- Sleep-disordered Breathing (SDB)
- Sleep Apnea
- Sleep Quality
Interventions
Smart Mask V1 SystemDevice
PPG-based sensors integrated into a PAP-compatible face mask to measure SpO2 and PR.
Primary outcomes
What the sponsor says the trial is designed to measure.
- SpO2 Accuracy (Arms)Time frame: During each hypoxia session (90-140 minutes)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Complementair Medisch Centrum (CMC) Europe
Genk, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.